Pau d'Arco, Taheebo, Lapacho, medical research

U. S. Patent No. 5,663,197   This patent proves that constituents extracted from the Tabebuia Avellanedae ( Pau d'Arco) tree bark "remarkably inhibits the growth" and "exhibits selective toxicity" of 23 specific types of cancer cells. The compound also "was found to inhibit the growth almost completely" and "cause necrosis (death)" in 12 specific types of malignant cancer tumors.

This article will summarise the results of clinical research studies conducted by the company, "Taheebo Japan Co., Ltd." located in Osaka , Japan . Clinical laboratory tests were conducted at Tokyo University and other profession medical laboratories which culminated in the issuance of United States Patent Number 5,663,197 on September 2, 1997. Click here to view U. S. Patent No. 5,663,197

Taheebo Japan then produced and marketed a substance called "NFD" which they marketed as a tea product and priced the product at $280.00(US) per pound.

Here are the 23 different types of cancer cells listed in the study:

·         Human Lung Adenocarcinoma A-549 Cells

·         Human Lung Adenocarcinoma VMRC-LCD

·         Human Lung Adenocarcinoma SK-LU-1

·         Human Lung Squamous Carcinoma

·         Human Colon Adenocarcinoma WiDr

·         Human Prostate Cancer LNCaP

·         Human Squamous Cell Carcinoma A-431

·         Human Cervical Carcinoma HeLa

·         Human Cholangiocarcinoma HuCC-T1

·         Mouse Melanima B16 (M4)

·         Human Malignant B-Cell Lymphoma

·         Human Chronic Myelogenous Leukemia K-562

·         Human Pancreatic Carcinoma ASPC-1

·         Human Neuroblastoma IMR-132

·         Human Urinary Bladder Carcinoma T24

·         Human Renal Cell Carcinoma VMRC-RCW

·         Human Gastric Cancer NUGC-2

·         Human Thyroid Carcinoma 8305C

·         Human Breast Cancer MRK-nu-1

·         Human Hepatoma HUH-7

·         Human Ovarian Carcinoma TYK-nu

·         Human Chorio Carcinoma BeWo

Here are the 12 different types of malignant tumors listed:

·         Human Lung Anenocarcinoma

·         Human Colon Anenocarcinoma

·         Squamous Cell Carcinoma

·         Cervical Carcinoma

·         Pancreatic Carcinoma

·         Lung Carcinoma

·         Bladder Carcinoma

·         Renal Cell Carcinoma

·         Thyroid Carcinoma

·         Cholangiocarcinoma

·         Ovarian Carcinoma

·         Chorio Carcinoma

This patent was approved and obtained on the results of scientific laboratory research studies. This study does not make any claims as to the results that may be attained when using the "NFD" product as a herbal remedy for cancer. Human research studies have not been done to date. Why haven't human research studies on such a promising herbal remedy been accomplished? We can only speculate...

Also, this study used only three of the constituents from the Pau d'Arco tree bark. There are over 30 different identified constituents that reside in this remarkable herb. As stated in Walter Lubeck's book, "The Healing Power of Pau d'Arco", "There wasn't just one individual "miracle active ingredient" in Pau D'Arco responsible for all the good results. Its extensive healing power originates in the totality of the substances contained within this plant, which we are completely justified in calling unique, and their fortunate balanced state and harmonious combination with each other. Because of the fantastic composition of the active ingredients, even the smallest amounts of the individual active ingredients can make a decisive contribution to processes like the inhibition of tumor growth. If the components are used in an isolated manner, much of their healing power disappears and the excellent tolerance and harmonious effect of the tea is often lost.

PAU D'ARCO TEA, has shown that it may hold the secret for the successful treatment of cancer and other diseases. Dr. Daniel B. Mowry, PhD, states in his widely published article on Pau d' Arco that "whole Lapacho has produced clinical anti-cancer effects without side effects." Read Dr. Mowry's extensive research and history of Pau d'Arco published here. Over the last 15 years I have received many reports and testimonials from terminal cancer victims relating their miraculous recovery from this deadly disease.

Medical practitioners in South America have used Pau D'Arco Tea as a primary treatment for cancer for many decades. I hear stories on a weekly basis that relate the remarkable results of using this amazing herbal remedy.

EARLY SCIENTIFIC WORK

Research on lapacho has been going on for a long time. E. Paterno isolated the active constituent, lapachol, in 1884. Inn 1896, S.C. Hooker established the chemical structure of lapachol, and L.F. Fieser synthesized the substance in 1927! So it would be a mistake to call lapacho a modern discovery.

As early as 1873, physicians were aware of the healing action of lapacho. Dr. Joaquin Almeida Pinto wrote during that year, "Pau D'Arco: Medicinal Properties: prescribed as a fever-reducer; the bark is used against ulcers; also used for venereal and rheumatic disorders and especially useful for skin disorders, especially eczema, herpes and the mange". Another early physician, Dr. Walter Accorsi, reported that lapacho, "eliminated the pains caused by the disease (cancer) and multiplies the body's production of red corpuscles."

However, the science of lapacho began properly with the work of Theodoro Meyer in Argentina who tried for decades with little success to convince the medical world of the value of lapacho for infections and cancer. Data from his laboratory are astounding in terms of the success rate observed when applying the herb in dozens of different kinds of cancer. Much of Meyer's work was primitive by modern research standards; most of it lacked adequate controls and statistical evaluation. But the sheer bulk of it is good evidence for the efficacy of lapacho. The Meyer era ended at his death in 1972, with the scientific world left still largely unconvinced of the usefulness of lapacho as a modern medicinal agent. Perhaps the most important thing Meyer accomplished, from a scientific point of view, was to bring lapacho to the attention of the rest of world, to extract the plant from the jungles of the Amazon, and announce, "Here is a folk remedy with great promise for all mankind."

Independent of Meyer, a physician in Brazil , about 1960, after hearing a tale of its miraculous curative powers, used lapacho to treat his brother who was lying in a Santo Andre , Brazil hospital, dying of cancer. His brother recovered, and the physician, Dr. Orlando dei Santi, began to use the herb to treat other cancer patients at the hospital. Other physicians joined the team, and after a few months, several case histories of cures were recorded. In the typical case, pain disappeared rapidly and sometimes complete remission was achieved in as little as four weeks.

Because of the work at the Municipal Hospital of Santo Andre, lapacho has become a standard form of treatment for some kinds of cancer and for all kinds of infections in medical establishments throughout Brazil . It should be noted that after the first reports of "miraculous" herbal cures appeared in Brazil , the national government ordered a blackout of any more public statements by doctors involved in the research. The silence was finally broken by Alec De Montmorency, who in 1981 published a lengthy review of the ongoing clinical work in Brazil . This report succeeded in stimulating worldwide interest in the plant.

In 1968, Dr. Prats Ruiz of Concepcion , Argentina , successfully treated three cases of leukemia in his private clinic. Some of these results were widely published and also helped to establish the popularity of lapacho among the "civilized" inhabitants of South American countries.

American physicians, of course, tend to look disparagingly upon the clinical evidence from backward areas of South America , preferring instead sanitized evidence from their own brightly lit laboratories. The weight of the South American clinical evidence has not been sufficient to cause widespread acceptance of the treatment outside South America , but it has stimulated research interest abroad. Pharmaceutical companies regularly screen lapacho for the presence of substances that could be the basis for new drug applications. As we shall see, however, no isolated component of lapacho comes anywhere close to being equal to the combined activity of all constituents, or, in other words, to the whole herb.

Drug Detox Observations. A common thread that runs throughout early and current empirical and clinical reports of lapacho treatment is the consistent observation that the herb eliminates many of the common side effects of the orthodox medications. There is no explanation of this action, but it is so often seen that one cannot easily doubt its validity. Pain, hair loss and immune dysfunction are among the symptoms most commonly eliminated.

This is a composite list of the various diseases and afflictions these research articles have mentioned when discussing Pau d'Arco. (Bibliography below)

Bibliography:

• "THE HEALING POWER OF PAU D' ARCO" By Walter Lubek, Lotus Light Publications

• " PAU D'ARCO - IMMUNE POWER from the Rain Forest" by Kenneth Jones, Healing Arts Press

• "NATURES WISDOM", Internet Article, 1998

• " PAU D'ARCO", Raintree Nutrition, Inc, Research Article, Leslie Taylor

• "ANCIENT HERB, MODERN MIRACLE" By Dr. D. Mowry, PhD, Mountainwest Institute of Herbal Sciences

• "SOUTH AMERICAN CANCER CURE", Alec de Montmorency, The Spotlight, June, 1981,

• "CANCER THERAPY" By Ralph Moss, PhD, Equinox Press

|  Pau D' Arco Tea - Order Here |  Description of Quality Pau D'arco |

|  Dosage  |  FAQs  |  Health Benefits  |  Preparation  |  Medical Research  |